Lydia Wunderle

Affiliations

Department of Medicine, Hematology and Oncology, Goethe University Hospital, Frankfurt, Germany.

Publications (1)

A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemia.

BMC pharmacology & toxicology

Avec: Fabian Lang , Lydia Wunderle , Susanne Badura , Eberhard Schleyer , Monika Brüggemann , Hubert Serve , Susanne Schnittger , Nicola Gökbuget , Heike Pfeifer , Sebastian Wagner , Kevin Ashelford , Gesine Bug , Oliver G Ottmann

Réseau de co-auteurs

Fabian Lang 1 collaboration

Susanne Badura 1 collaboration

Eberhard Schleyer 1 collaboration

Monika Brüggemann 1 collaboration

Hubert Serve 1 collaboration

Susanne Schnittger 1 collaboration

Nicola Gökbuget 1 collaboration

Heike Pfeifer 1 collaboration

Sebastian Wagner 1 collaboration

Kevin Ashelford 1 collaboration

Gesine Bug 1 collaboration

Oliver G Ottmann 1 collaboration